Immunopathogenesis of vitiligo

Abstract Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Autoimmunity reviews 2011-10, Vol.10 (12), p.762-765
Hauptverfasser: Sandoval-Cruz, Manuel, García-Carrasco, Mario, Sánchez-Porras, Renán, Mendoza-Pinto, Claudia, Jiménez-Hernández, Mario, Munguía-Realpozo, Pamela, Ruiz-Argüelles, Alejandro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 765
container_issue 12
container_start_page 762
container_title Autoimmunity reviews
container_volume 10
creator Sandoval-Cruz, Manuel
García-Carrasco, Mario
Sánchez-Porras, Renán
Mendoza-Pinto, Claudia
Jiménez-Hernández, Mario
Munguía-Realpozo, Pamela
Ruiz-Argüelles, Alejandro
description Abstract Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explain the pathomechanisms involved in this disease, and studies have shown the participation of autoimmune processes in the pathogenesis of vitiligo. Cellular and humoral immunities have been implicated in the development of vitiligo and their role continues to be investigated. Peripheral blood and skin biopsies of patients with vitiligo show that T-cells, mononuclear cells, various pro-inflammatory cytokines, and auto-antibodies can damage melanocytes. Further research is required to determine whether autoimmunity is the main mechanism of vitiligo or only a consequence.
doi_str_mv 10.1016/j.autrev.2011.02.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904480813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1568997211000309</els_id><sourcerecordid>904480813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-d262b0f4089e436dcfc64fcf7f96afe62fe954d23794d2d66111ce3cd7fa4eb83</originalsourceid><addsrcrecordid>eNqFkT9PwzAQxS0EoqXwDVDVjanh7LhuvCAhxJ9KlRiA2Uqdc3FI4mInlfrtcZWCEAvL-Yb37p1_R8glhYQCFddlknetx23CgNIEWALAj8iQzkQ2lXLOjn_1A3IWQgnRJpk8JQNG05RzwYdkvKjrrnGbvH13a2ww2DBxZrK1ra3s2p2TE5NXAS8O74i8Pdy_3j1Nl8-Pi7vb5VRznrXTggm2AsMhk8hTUWijBTfazI0UuUHBDMoZL1g6l7EWQlBKNaa6mJuc4ypLR-Sqn7vx7rPD0KraBo1VlTfouqAkxBzI4tojwnul9i4Ej0ZtvK1zv1MU1B6MKlUPRu3BKGAqgom28SGgW9VY_Ji-SUTBTS_A-M2tRa-CtthoLKxH3arC2f8S_g7QlW2szqsP3GEoXeebiFBRFaJBveyPs78NpQCQgky_AEJoipw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>904480813</pqid></control><display><type>article</type><title>Immunopathogenesis of vitiligo</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sandoval-Cruz, Manuel ; García-Carrasco, Mario ; Sánchez-Porras, Renán ; Mendoza-Pinto, Claudia ; Jiménez-Hernández, Mario ; Munguía-Realpozo, Pamela ; Ruiz-Argüelles, Alejandro</creator><creatorcontrib>Sandoval-Cruz, Manuel ; García-Carrasco, Mario ; Sánchez-Porras, Renán ; Mendoza-Pinto, Claudia ; Jiménez-Hernández, Mario ; Munguía-Realpozo, Pamela ; Ruiz-Argüelles, Alejandro</creatorcontrib><description>Abstract Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explain the pathomechanisms involved in this disease, and studies have shown the participation of autoimmune processes in the pathogenesis of vitiligo. Cellular and humoral immunities have been implicated in the development of vitiligo and their role continues to be investigated. Peripheral blood and skin biopsies of patients with vitiligo show that T-cells, mononuclear cells, various pro-inflammatory cytokines, and auto-antibodies can damage melanocytes. Further research is required to determine whether autoimmunity is the main mechanism of vitiligo or only a consequence.</description><identifier>ISSN: 1568-9972</identifier><identifier>EISSN: 1568-9972</identifier><identifier>EISSN: 1873-0183</identifier><identifier>DOI: 10.1016/j.autrev.2011.02.004</identifier><identifier>PMID: 21334464</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Allergy and Immunology ; Autoimmune Diseases - complications ; Autoimmunity ; Humans ; Melanocyte ; Melanocytes - immunology ; Melanocytes - pathology ; Pathogenesis ; Vitiligo ; Vitiligo - immunology ; Vitiligo - pathology</subject><ispartof>Autoimmunity reviews, 2011-10, Vol.10 (12), p.762-765</ispartof><rights>2011</rights><rights>Copyright © 2011. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-d262b0f4089e436dcfc64fcf7f96afe62fe954d23794d2d66111ce3cd7fa4eb83</citedby><cites>FETCH-LOGICAL-c448t-d262b0f4089e436dcfc64fcf7f96afe62fe954d23794d2d66111ce3cd7fa4eb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.autrev.2011.02.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21334464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sandoval-Cruz, Manuel</creatorcontrib><creatorcontrib>García-Carrasco, Mario</creatorcontrib><creatorcontrib>Sánchez-Porras, Renán</creatorcontrib><creatorcontrib>Mendoza-Pinto, Claudia</creatorcontrib><creatorcontrib>Jiménez-Hernández, Mario</creatorcontrib><creatorcontrib>Munguía-Realpozo, Pamela</creatorcontrib><creatorcontrib>Ruiz-Argüelles, Alejandro</creatorcontrib><title>Immunopathogenesis of vitiligo</title><title>Autoimmunity reviews</title><addtitle>Autoimmun Rev</addtitle><description>Abstract Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explain the pathomechanisms involved in this disease, and studies have shown the participation of autoimmune processes in the pathogenesis of vitiligo. Cellular and humoral immunities have been implicated in the development of vitiligo and their role continues to be investigated. Peripheral blood and skin biopsies of patients with vitiligo show that T-cells, mononuclear cells, various pro-inflammatory cytokines, and auto-antibodies can damage melanocytes. Further research is required to determine whether autoimmunity is the main mechanism of vitiligo or only a consequence.</description><subject>Allergy and Immunology</subject><subject>Autoimmune Diseases - complications</subject><subject>Autoimmunity</subject><subject>Humans</subject><subject>Melanocyte</subject><subject>Melanocytes - immunology</subject><subject>Melanocytes - pathology</subject><subject>Pathogenesis</subject><subject>Vitiligo</subject><subject>Vitiligo - immunology</subject><subject>Vitiligo - pathology</subject><issn>1568-9972</issn><issn>1568-9972</issn><issn>1873-0183</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT9PwzAQxS0EoqXwDVDVjanh7LhuvCAhxJ9KlRiA2Uqdc3FI4mInlfrtcZWCEAvL-Yb37p1_R8glhYQCFddlknetx23CgNIEWALAj8iQzkQ2lXLOjn_1A3IWQgnRJpk8JQNG05RzwYdkvKjrrnGbvH13a2ww2DBxZrK1ra3s2p2TE5NXAS8O74i8Pdy_3j1Nl8-Pi7vb5VRznrXTggm2AsMhk8hTUWijBTfazI0UuUHBDMoZL1g6l7EWQlBKNaa6mJuc4ypLR-Sqn7vx7rPD0KraBo1VlTfouqAkxBzI4tojwnul9i4Ej0ZtvK1zv1MU1B6MKlUPRu3BKGAqgom28SGgW9VY_Ji-SUTBTS_A-M2tRa-CtthoLKxH3arC2f8S_g7QlW2szqsP3GEoXeebiFBRFaJBveyPs78NpQCQgky_AEJoipw</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Sandoval-Cruz, Manuel</creator><creator>García-Carrasco, Mario</creator><creator>Sánchez-Porras, Renán</creator><creator>Mendoza-Pinto, Claudia</creator><creator>Jiménez-Hernández, Mario</creator><creator>Munguía-Realpozo, Pamela</creator><creator>Ruiz-Argüelles, Alejandro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20111001</creationdate><title>Immunopathogenesis of vitiligo</title><author>Sandoval-Cruz, Manuel ; García-Carrasco, Mario ; Sánchez-Porras, Renán ; Mendoza-Pinto, Claudia ; Jiménez-Hernández, Mario ; Munguía-Realpozo, Pamela ; Ruiz-Argüelles, Alejandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-d262b0f4089e436dcfc64fcf7f96afe62fe954d23794d2d66111ce3cd7fa4eb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Allergy and Immunology</topic><topic>Autoimmune Diseases - complications</topic><topic>Autoimmunity</topic><topic>Humans</topic><topic>Melanocyte</topic><topic>Melanocytes - immunology</topic><topic>Melanocytes - pathology</topic><topic>Pathogenesis</topic><topic>Vitiligo</topic><topic>Vitiligo - immunology</topic><topic>Vitiligo - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sandoval-Cruz, Manuel</creatorcontrib><creatorcontrib>García-Carrasco, Mario</creatorcontrib><creatorcontrib>Sánchez-Porras, Renán</creatorcontrib><creatorcontrib>Mendoza-Pinto, Claudia</creatorcontrib><creatorcontrib>Jiménez-Hernández, Mario</creatorcontrib><creatorcontrib>Munguía-Realpozo, Pamela</creatorcontrib><creatorcontrib>Ruiz-Argüelles, Alejandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Autoimmunity reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sandoval-Cruz, Manuel</au><au>García-Carrasco, Mario</au><au>Sánchez-Porras, Renán</au><au>Mendoza-Pinto, Claudia</au><au>Jiménez-Hernández, Mario</au><au>Munguía-Realpozo, Pamela</au><au>Ruiz-Argüelles, Alejandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunopathogenesis of vitiligo</atitle><jtitle>Autoimmunity reviews</jtitle><addtitle>Autoimmun Rev</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>10</volume><issue>12</issue><spage>762</spage><epage>765</epage><pages>762-765</pages><issn>1568-9972</issn><eissn>1568-9972</eissn><eissn>1873-0183</eissn><abstract>Abstract Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explain the pathomechanisms involved in this disease, and studies have shown the participation of autoimmune processes in the pathogenesis of vitiligo. Cellular and humoral immunities have been implicated in the development of vitiligo and their role continues to be investigated. Peripheral blood and skin biopsies of patients with vitiligo show that T-cells, mononuclear cells, various pro-inflammatory cytokines, and auto-antibodies can damage melanocytes. Further research is required to determine whether autoimmunity is the main mechanism of vitiligo or only a consequence.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>21334464</pmid><doi>10.1016/j.autrev.2011.02.004</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1568-9972
ispartof Autoimmunity reviews, 2011-10, Vol.10 (12), p.762-765
issn 1568-9972
1568-9972
1873-0183
language eng
recordid cdi_proquest_miscellaneous_904480813
source MEDLINE; Elsevier ScienceDirect Journals
subjects Allergy and Immunology
Autoimmune Diseases - complications
Autoimmunity
Humans
Melanocyte
Melanocytes - immunology
Melanocytes - pathology
Pathogenesis
Vitiligo
Vitiligo - immunology
Vitiligo - pathology
title Immunopathogenesis of vitiligo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A56%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunopathogenesis%20of%20vitiligo&rft.jtitle=Autoimmunity%20reviews&rft.au=Sandoval-Cruz,%20Manuel&rft.date=2011-10-01&rft.volume=10&rft.issue=12&rft.spage=762&rft.epage=765&rft.pages=762-765&rft.issn=1568-9972&rft.eissn=1568-9972&rft_id=info:doi/10.1016/j.autrev.2011.02.004&rft_dat=%3Cproquest_cross%3E904480813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=904480813&rft_id=info:pmid/21334464&rft_els_id=1_s2_0_S1568997211000309&rfr_iscdi=true